Intensive care patients - activities

Coronavirus : En France, la rémunération des gardes des internes dans les hôpitaux augmente de 25%Coronavirus : En France, la rémunération des gardes des internes dans les hôpitaux augmente de 25%Coronavirus : En France, la rémunération des gardes des internes dans les hôpitaux augmente de 25%Coronavirus : En France, la rémunération des gardes des internes dans les hôpitaux augmente de 25%

Covid: the second wave’s peak almost reached with circa 4,900 patients in ICU

The hospitals’ health situation grows worrying by the day. As of Sunday March 28 evening, 4,872 Covid-19 sick were hospitalized in intensive care units; a data all the more so worrying it is now verging on the peak of the second wave reached this past Fall.
Taux d'incidence, hôpitaux : ces chiffres qui laissent croire au reconfinement en Île-de-FranceTaux d'incidence, hôpitaux : ces chiffres qui laissent croire au reconfinement en Île-de-FranceTaux d'incidence, hôpitaux : ces chiffres qui laissent croire au reconfinement en Île-de-FranceTaux d'incidence, hôpitaux : ces chiffres qui laissent croire au reconfinement en Île-de-France

Covid: Martin Hirsch fears boom in ICU admissions in early April

As new decisions might be made in the coming hours to curb the spread of the Covid-19 epidemic in Île-de-France, Martin Hirsch shared his concerns this March 17 on RTL. AP-HP director fears a boom in ICU admissions. According to Assistance Publique – Hôpitaux de Paris’s predictions, up to 2,800 patients might be hospitalized in intensive care in early April.
Coronavirus : Le tocilizumab, le nouveau médicament prometteurCoronavirus : Le tocilizumab, le nouveau médicament prometteurCoronavirus : Le tocilizumab, le nouveau médicament prometteurCoronavirus : Le tocilizumab, le nouveau médicament prometteur

Tocilizumab, the covid treatment to dramatically reduce deaths, Recovery says

This Thursday February 11, the Oxford University released the results of Recovery clinical trial on Tocilizumab, a medication generally used in rheumatology, but here, it is used to lower the number of Covid patients in ICU. And results are particularly encouraging, echoing the study led in April 2020 by AP-HP. Here is more on the matter.